The European Commission published Version 7 of
the questions and answers about safety features in June
2017. Compared to the previous version, eight new questions and answers have
been added; also, six questions and answers have been revised. In total, the
document now contains 65 questions and answers
about safety features.
Question 1.15 has been newly added, for example, about whether
there would be financial support for the implementation of safety features by
the EU (or national). This question was negated.
Also newly added was question 2.14 about whether the Delegated
Regulation would set guidelines on how the safety features should be applied to
the outer packaging. The answer states that the Delegated Regulations do not
contain any specific guidelines about the placement of the safety
features on the outer packaging. It is therefore up the individual
pharmaceutical manufacturer how he wishes to implement the safety features.
Question 1.2 confirmed the ambitious
schedule. All European states with the exception of Belgium,
Greece and Italy must have the newly-mandatory safety features implemented by February 9th, 2019.
Please also read version 7 of the questions and answers of the EU Commission about safety
features for further details.
0 comments:
Post a Comment